Whyte Chemicals to Distribute Shell’s PDO

Today Shell Chemicals Europe BV ("Shell") and Whyte Chemicals Ltd. ("Whyte") announced they have formed an agreement in which Whyte will handle distribution of Shell's 1,3 propanediol monomer (PDO) in the European chemicals marketplace. Whyte will add PDO to its portfolio within the Process Chemicals and Intermediates division.

"Shell is pleased to be associated with Whyte because it is a competitive source of solvents and a reliable supplier to a wide range of industries," says Frank Schnitzeler, European Commercial Manager PDO/CORTERRA. "Whyte specializes in sourcing products for specific and novel applications, and PDO is a good fit with their portfolio of value-added products. "

PDO can be formulated into composites, adhesives, laminates, powder and UV-cured coatings, mouldings, novel aliphatic polyesters, co-polyesters, solvents, fine chemical synthesis, anti-freeze and other end uses. It has successfully been used to formulate CORTERRAtm Polymers, a polytrimethylene terephthalate (PTT), which is used to make carpet and textile fibers, engineering thermoplastics, films and coatings. Once expensive and laborious to produce, Shell Chemicals commercialised a proprietary process in 1999 that now enables PDO to be cost efficient and competitive with similar compounds.

Whyte Chemicals Limited, a subsidiary of Whyte Group Ltd, is a respected chemical distribution company servicing companies worldwide. Its reputation is based on first class service and fast and efficient distribution from a strategically positioned chain of dedicated warehouses, bulk storage facilities and transport fleet.

For more information on adhesives, click here.

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.